Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
9.8%
% of IXJ's 112 holdings also in MEDX
36.7%
% of MEDX's 30 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.0% | 16.0% | 9.0% |
|
JOHNSON & JOHNSON | 4.8% | 4.4% | 4.4% |
|
MERCK & CO. INC. | 4.2% | 4.7% | 4.2% |
|
ABBVIE INC | 4.0% | 7.4% | 4.0% |
|
AMGEN INC | 2.3% | 6.2% | 2.3% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 6.8% |
 |
NOVO NORDISK A/S-B | 5.5% |
 |
ASTRAZENECA PLC | 3.2% |
 |
ROCHE HOLDING LTD | 2.9% |
|
NOVARTIS AG | 2.8% |
|
THERMO FISHER SCIENTIFIC INC | 2.7% |
|
ABBOTT LABORATORIES | 2.3% |
|
INTUITIVE SURGICAL INC | 2.1% |
|
DANAHER CORP | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 1.7% |
IXJ Underweight Relative to MEDX
|
ELI LILLY & CO | -7.0% |
|
NOVARTIS AG-ADR | -5.7% |
|
ASTRAZENECA PLC-SPONS ADR | -5.5% |
|
AMGEN INC | -3.9% |
|
ALNYLAM PHARMACEUTICALS INC | -3.8% |
|
BIOGEN IDEC INC | -3.5% |
|
ABBVIE INC | -3.4% |
|
IONIS PHARMACEUTICALS, INC. | -3.3% |
|
CRISPR THERAPEUTICS AG | -3.2% |
 |
ALKERMES PLC | -3.2% |